Skip to content

Clinical trials

Completed Phase 3 Osteoporosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Phase: Phase 3 Status: Completed Clear all

150 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
200110
200212
200312
200419
200512
200615
200711
20089
20099
20106
20117
20124
20142
20161
20172
20184
20192
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed150

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen17
Novartis Pharmaceuticals13
Eli Lilly and Company8
Organon and Co6
Radius Health, Inc.5
Alliance for Clinical Trials in Oncology4
Merck Sharp & Dohme LLC4
Novartis4
Shire4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis150
Bone Diseases, Metabolic37
Osteoporosis, Postmenopausal23
Breast Neoplasms11
Fractures, Bone11
Prostatic Neoplasms6
Bone Diseases5
Osteoporotic Fractures4
Cardiovascular Diseases3
Hip Fractures3

Trials

Showing 1 to 25 of 150. Each trial links to its page on Pharma Observatory.

50 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.